NO20003956L - Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten - Google Patents

Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten

Info

Publication number
NO20003956L
NO20003956L NO20003956A NO20003956A NO20003956L NO 20003956 L NO20003956 L NO 20003956L NO 20003956 A NO20003956 A NO 20003956A NO 20003956 A NO20003956 A NO 20003956A NO 20003956 L NO20003956 L NO 20003956L
Authority
NO
Norway
Prior art keywords
loop
vector containing
adenovirus vector
peptide epitope
heterologous peptide
Prior art date
Application number
NO20003956A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003956D0 (no
Inventor
David T Curiel
Victor N Krasnykh
Igor Dmitriev
Original Assignee
Uab Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation filed Critical Uab Research Foundation
Publication of NO20003956D0 publication Critical patent/NO20003956D0/no
Publication of NO20003956L publication Critical patent/NO20003956L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20003956A 1998-02-06 2000-08-04 Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten NO20003956L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7394798P 1998-02-06 1998-02-06
US9980198P 1998-09-10 1998-09-10
PCT/US1999/002549 WO1999039734A1 (fr) 1998-02-06 1999-02-05 Vecteur adenoviral contenant un epitope peptidique heterologue dans la boucle hi du bouton de fibre

Publications (2)

Publication Number Publication Date
NO20003956D0 NO20003956D0 (no) 2000-08-04
NO20003956L true NO20003956L (no) 2000-10-05

Family

ID=26755086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003956A NO20003956L (no) 1998-02-06 2000-08-04 Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten

Country Status (11)

Country Link
US (1) US7297542B2 (fr)
EP (1) EP1053013A4 (fr)
JP (1) JP2002507391A (fr)
KR (1) KR20010034487A (fr)
CN (1) CN1304316A (fr)
AU (1) AU744252B2 (fr)
BR (1) BR9908613A (fr)
CA (1) CA2327545A1 (fr)
IL (1) IL137681A0 (fr)
NO (1) NO20003956L (fr)
WO (1) WO1999039734A1 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395875B1 (en) * 1999-01-25 2002-05-28 Brookhaven Science Associates Llc Recombinant soluble adenovirus receptor
US7157266B2 (en) * 1999-01-25 2007-01-02 Brookhaven Science Associates Llc Structure of adenovirus bound to cellular receptor car
CA2392272A1 (fr) 1999-11-25 2001-05-31 Transgene S.A. Fibre adenovirable modifiee et utilisations
ES2244607T3 (es) 2000-04-12 2005-12-16 Amersham Health As Derivados peptidicos de union a integrina.
JP3635462B2 (ja) 2000-05-31 2005-04-06 国立医薬品食品衛生研究所長 アデノウイルスベクター
US6849446B2 (en) 2000-05-31 2005-02-01 University Of Saskatchewan Modified bovine adenovirus having altered tropism
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
HU230901B1 (hu) 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
EP1446479B1 (fr) 2001-09-29 2012-08-15 Chae-Ok Yun Adenovirus recombinant a effet therapeutique ameliore et composition pharmaceutique comprenant ledit adenovirus recombinant
CA2491805A1 (fr) * 2002-07-10 2004-01-22 Transgene S.A. Fibre adenovirale modifiee par ablation de la liaison aux recepteurs cellulaires
WO2005027711A2 (fr) * 2003-05-01 2005-03-31 University Of Washington Vecteurs d'adenovirus a capside modifiee et methodes d'utilisation
US7611868B2 (en) 2003-05-14 2009-11-03 Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Recombinant modified adenovirus fiber protein
CA2543200A1 (fr) * 2003-10-24 2005-05-06 National Research Council Of Canada Systeme ligand-pseudorecepteur generant des vecteurs adenoviraux a tropisme altere
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
WO2005072854A1 (fr) 2004-02-02 2005-08-11 The University Of British Columbia Scodaphorese, procedes et appareil utilises pour deplacer et concentrer des particules
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US7473418B2 (en) 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
DE102004021584A1 (de) * 2004-05-03 2005-12-01 Stefan Kochanek Modifizierte virale Vektorpartikel
US7776322B2 (en) 2004-08-16 2010-08-17 Stefan Kochanek Modified viral vector particles
CA2496294A1 (fr) * 2005-02-07 2006-08-07 The University Of British Columbia Appareil et methodes pour concentrer et separer des particules comme des molecules
WO2007123737A2 (fr) 2006-03-30 2007-11-01 University Of California Procédés et compositions de sécrétion localisée d'anticorps anti-ctla-4
US7919079B2 (en) 2006-03-31 2011-04-05 Biosante Pharmaceuticals, Inc. Cancer immunotherapy compositions and methods of use
US20100272753A1 (en) * 2006-10-26 2010-10-28 The Johns Hopkins University Recombinant Adenovirus Vaccines
EP2238434A4 (fr) * 2008-02-01 2011-06-22 Univ British Columbia Procédés et appareil pour l'introduction et la récupération de particules
US8791239B2 (en) * 2008-05-04 2014-07-29 University Of Maryland, College Park Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same
EP2374002A1 (fr) 2008-12-23 2011-10-12 GE Healthcare UK Limited Application d'un composé basé sur le peptide 99mtc à l'imagerie de la moelle osseuse
US8877028B2 (en) 2009-04-21 2014-11-04 The University Of British Columbia System and methods for detection of particles
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
WO2012006145A2 (fr) * 2010-06-29 2012-01-12 The Johns Hopkins University Compositions et procédés pour le reciblage de constructions virales
CA2742327A1 (fr) 2011-05-20 2012-11-20 The University Of British Columiba Systemes et methodes pour amelioration de la scoda (separation, concentration, detection de molecules selon la difference d'affinite de liaison)
US9267153B2 (en) * 2011-12-15 2016-02-23 Washington University Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
WO2013104994A2 (fr) 2012-01-13 2013-07-18 The University Of British Columbia Appareil à bras multiples et procédés pour la séparation de particules
CA2867129C (fr) * 2012-03-13 2023-11-21 Salk Institute For Biological Studies Ciblage cellulaire selectif a l'aide d'adenovirus et de dimeres chimiques
WO2013166444A2 (fr) 2012-05-04 2013-11-07 Boreal Genomics Corp. Analyse de biomarqueurs utilisant la scodaphorèse
JP6576326B2 (ja) 2013-03-14 2019-09-18 ソーク インスティテュート フォー バイオロジカル スタディーズ 腫瘍溶解性アデノウイルス組成物
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
CN104634978A (zh) * 2013-11-13 2015-05-20 长春百克生物科技股份公司 一种分型检测腺病毒中和抗体的方法以及用于分型检测腺病毒中和抗体的试剂盒
EP3180034B1 (fr) * 2014-08-11 2022-04-20 The Board of Regents of The University of Texas System Prévention de la dystrophie musculaire par édition de gène médiée par crispr/cas9
US11130986B2 (en) 2015-05-20 2021-09-28 Quantum-Si Incorporated Method for isolating target nucleic acid using heteroduplex binding proteins
CA3013637A1 (fr) 2016-02-23 2017-08-31 Salk Institute For Biological Studies Dosage a haut debit pour mesurer la cinetique de replication d'un adenovirus
AU2017223589B2 (en) 2016-02-23 2023-08-03 Salk Institute For Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
WO2018111767A1 (fr) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Adénovirus synthétiques ciblant une tumeur et leurs utilisations
US20180169271A1 (en) 2016-12-21 2018-06-21 Memgen, Llc Armed replication-competent oncolytic adenoviruses
KR20240149451A (ko) 2017-06-27 2024-10-14 리제너론 파마슈티칼스 인코포레이티드 유전 물질을 인간 세포 내로 표적화하여 도입하기 위한 향성-변형 재조합 바이러스 벡터 및 이의 용도
EP3927833A4 (fr) 2019-02-21 2022-11-30 Unleash Immuno Oncolytics, Inc. Vecteur adénoviral oncolytique et procédés d'utilisation
CA3159566A1 (fr) 2019-10-29 2021-05-06 Quantum-Si Incorporated Pompage peristaltique de fluides et procedes, systemes et dispositifs associes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
JP2001520511A (ja) * 1995-12-08 2001-10-30 ザ ユーナヴァーサティ オブ アラバマ アト バーミングハム リサーチ ファンデーション 向標的性アデノウイルス・ベクター
ATE540686T1 (de) * 1999-05-12 2012-01-15 Uab Research Foundation Adenovirus mit erhöhter infektiosität und konditionaler replikationsfähigkeit und deren verwendungen

Also Published As

Publication number Publication date
NO20003956D0 (no) 2000-08-04
CN1304316A (zh) 2001-07-18
EP1053013A4 (fr) 2004-12-22
CA2327545A1 (fr) 1999-08-12
EP1053013A1 (fr) 2000-11-22
AU2659599A (en) 1999-08-23
KR20010034487A (ko) 2001-04-25
US7297542B2 (en) 2007-11-20
IL137681A0 (en) 2001-10-31
US20020081280A1 (en) 2002-06-27
WO1999039734A1 (fr) 1999-08-12
AU744252B2 (en) 2002-02-21
JP2002507391A (ja) 2002-03-12
BR9908613A (pt) 2000-10-31

Similar Documents

Publication Publication Date Title
NO20003956L (no) Adenovirusvektor som inneholder en heterolog peptidepitop i HI-løkken til fiberknuten
DE69422632D1 (de) Antigen enthaltende nicht-ionische Tensid Vesikel
DE69833503D1 (de) Mechanismus der unterbrechung von bestimmungsortredirektion ausführt
FI930836A0 (fi) Topiska preparat som innehaoller cyklosporin
DE69835976D1 (de) Polarisationsunabhängiger optischer Phasenmodulator
FI924982A0 (fi) Frystorkat preparat som innehaoller monoklonal motkropp
DE69527565D1 (de) Stabiles einphasiges selbstschäumendes Reinigungsmittel
NO20006056D0 (no) Optiske fiberbånd som inneholder strålingsherdede innkapslingsmaterialer
DK12893D0 (da) Fremgangsmaade til fremstilling af normal saavel som ultrafin cement
ID20789A (id) Zat pemutih fluoresen
DK0813876T3 (da) Cyclosporinholdigt præparat i form af en blød kapsel
FI925246A0 (fi) Fluorerade aldoketendimerer och deras anvaendning som kombinerade olje och vatten resistenta lim foer cellulosa material
DK1109450T3 (da) Mikrokapselpræparater
DK0940712T3 (da) Projektionsskræm
DE69710165D1 (de) Phasenregelschleife
FI970727A0 (fi) Foerfarande och anordning foer torkning av objekt som innehaoller vatten
FR2767634B1 (fr) Godet desileur
ZA200003905B (en) Adenovirus Vector containing A Heterologous Peptide Epitope in the HI Loop of the Fiber Knob.
NO984307D0 (no) Anvendelsen av spesielle tilberedninger som avskummere
FI973491A0 (fi) Markeringsmaolning och distributionsfoerpackning som anvaender en laogtrycksbehaollare foer densamma
FI963615A (fi) Peptidit, jotka estävät pepsiinin vapautumisen
FR2759536B1 (fr) Godet desileur
NO305192B1 (no) Ryggsekkforankring
FI973017A0 (fi) Vedeldad bastuugn som uppvaermer vatten i tryckvattennaet
FI971519A0 (fi) Sits som foerblir ren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application